Originally Aired: June 24, 2022
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

The inherent complexity of cancer provides investigators and clinicians with a challenging mix of cells in various states to fully understand disease biology and inform therapeutic decisions. Empowering cancer researchers to explore fundamental biological questions that were previously inconceivable is why the Tapestri from Mission Bio was designed. Quantitative characterization of genotype and phenotype at the single-cell level reveals clonal phylogeny and selection at higher resolution, which should ultimately enable better personalized therapeutic selection. Thus, by identifying SNVs, CNVs and surface protein expression changes in the same cellular background, Tapestri enables comprehensive insights into disease progression, development of resistance, and measurable residual disease (MRD).

For this Inside Precision Medicine webinar, our guest presenters, Dr. Todd Druley and Aaron Llanso will discuss applying single-cell DNA sequencing to MRD, clonal hematopoiesis (CHIP), solid tumor, and precision medicine. In addition, our presenters will describe how to track the clonal evolution of cancer with single-cell DNA sequencing and how to link genotype and phenotype with multiomics—all while providing new translational applications for the clinic.

A live Q&A followed the presentation, offering a chance to pose questions to our expert panelists.

Todd Druley
Todd Druley, MD, PhD
Chief Medical Officer
Mission Bio
Aaron Llanso
Aaron Llanso
Senior Director of Clinical Applications
Mission Bio

MissionBio Logo
Also of Interest